Effect of curing Helicobacter pylori infection on intragastric acidity during treatment with ranitidine in patients with duodenal ulcer

Gut

Volumn 41, Issue 1, 1997, Pages 33-36

  Labenz, J ^a   Tillenburg, B ^a   Peitz, U ^a   Verdu E ^b   Stolte, M ^c   Borsch G ^a   Blum, A L ^b  

^a ELISABETH KRANKENHAUS ESSEN   (Germany)

^b LAUSANNE UNIVERSITY HOSPITAL   (Switzerland)

^c INSTITUTE OF PATHOLOGY   (Germany)

Author keywords

Helicobacter pylori; Intragastric acidity; Omeprazole; Ranitidine

Indexed keywords

AMOXICILLIN; CARBON 13; CLARITHROMYCIN; GASTRIN; OMEPRAZOLE; RANITIDINE; UREA; UREASE;

ADULT; AGED; ARTICLE; BACTERIUM CULTURE; BREATH ANALYSIS; CLINICAL ARTICLE; DUODENUM ULCER; ENDOSCOPY; FEMALE; GASTRITIS; GRAM NEGATIVE INFECTION; HELICOBACTER PYLORI; HISTOLOGY; HUMAN; HUMAN TISSUE; MALE; PRIORITY JOURNAL; RADIOIMMUNOASSAY; STOMACH; STOMACH BIOPSY; STOMACH PH;

EID: 0030838047     PISSN: 00175749     EISSN: None     Source Type: Journal    
DOI: 10.1136/gut.41.1.33     Document Type: Article

References (21)

1. Labenz J, Tillenburg B, Peitz U, Idström J-P, Verdu EF, Stolte M, et al. Helicobacter pylori augments the pH-increasing effect of omeprazole in patients with duodenal ulcer. Gastroenterology 1996; 110: 725-32.
2. Verdú E, Armstrong D, Idström J-P, Labenz J, Stolte M, Dorta G, et al. Effect of curing Helicobacter pylori infection on intragastric pH during treatment with omeprazole. Gut 1995; 37: 743-8.
3. Goggin PM, Marrero JM, Ahmed H, Jackson PA, Corbishley SM, Northfield TC. Urea hydrolysis in Helicobacter pylori infection. Eur J Gastroenterol Hepatol 1991; 3: 927-33.
4. Triebling AT, Korsten MA, Dlugosz JW, Paronetto F, Lieber ChS. Severity of Helicobacter-induced gastric injury correlates with gastric juice ammonia. Dig Dis Sci 1991; 36: 1089-96.
5. Logan RP, Walker MM, Misiewicz JJ, Gummett PA, Karim QN, Baron JH. Changes in the intragastric distribution of Helicobacter pylori during treatment with omeprazole. Gut 1995; 36: 12-6.
6. Feldman M, Cryer B, McArthur KE, Lee E. Relationship between severity of H pylori (HP) gastritis and gastric acid-pepsin secretion in man. Gastroenterology 1996; 110: A106.
7. Labenz J, Stolte M, Aygen S, Hennemann O, Bertrams J, Borsch G. Qualitative and semiquantitative invasive and non-invasive assessment of Helicobacter pylori colonisation of the gastric mucosa. J Gastroenterol 1993; 31: 437-43.
8. Stolte M, Stadelmann O, Bethke B, Burkard G. Relationships between the degree of Helicobacter pylori colonisation and the degree and activity of gastritis, surface epithelial degeneration, and mucus secretion. Z Gastroenterol 1995; 33: 89-93.
9. 2 excess with Helicobacter pylori density, grade and activity of gastritis. Gastroenterology 1995; 108: A139.
10. Bercik P, Verdu EF, Armstrong D, Cederberg C, Idström J-P, Stolte M, Blum AL. H pylori related increase in omeprazole (OME) effect is associated with ammonia production. Gastroenterology 1996; 110: A64.
11. Noach LA, Bosma NB, Jansen J, Hoek FJ, van Deventer SJ, Tytgat GN. Mucosal tumor necrosis factor-α, interleukin-1β, and interleukin-8 production in patients with Helicobacter pylori infection. Scand J Gastroenterol 1994; 29: 425-9.
12. Peek RM, Miller GG, Tham KT, Perez-Perez GI, Zhao X, Atherton JC, Blaser MJ. Heightened inflammatory response and cytokine expression in vivo to cagA+ Helicobacter pylori strains. Lab Invest 1995; 73: 760-70.
13. Yasunaga Y, Shinomura Y, Kanayama S, Higashimoto Y, Yabu M, Nakanishi T, et al. Increased fundic mucosal interleukin-1α and hepatocyte growth factor release in H pylori associated enlarged fold gastritis. Gastroenterology 1995; 108: A263.
14. Prinz C, Schepp W, Classen M, Zeng N-X, Sachs G. Interleukin and EGF/TGFα effects on isolated rat enterochromaffin-like cells. Gastroenterology 1995; 108: A196.
15. 11-methylhistamine. Gastroenterology 1995; 108: 959-66.
16. Stolte M, Bethke B. Elimination of Helicobacter pylori under treatment with omeprazole. Z Gastroenterol 1991; 28: 271-4.
17. Esplugues JV, Barrachina MD, Calatayud S, Pique JM, Whittle BJ. Nitric oxide mediates the inhibition by interleukin-1β of pentagastrin-stimulated rat gastric acid secretion. Br J Pharmacol 1993; 108: 9-10.
18. Robert A, Olafsson AS, Lancaster C, Zhang WR. Interleukin-1 is cytoprotective, antisecretory, stimulates PGE2 synthesis by the stomach, and retards gastric emptying. Life Sci 1991; 48: 123-34.
19. Taché Y, Saperas E. Potent inhibition of gastric acid secretion and ulcer formation by centrally and peripherally administered interleukin-1α. Ann NY Acad Sci 1992; 664: 353-68.
20. Labenz J, Tillenburg B, Peitz U, Idström J-P, Verdú E, Stolte M, et al. Irreversible fall of efficacy of omeprazole (OME) after cure of H pylori (HP) infection in duodenal ulcer (DU) patients. Gastroenterology 1996; 110: A166.
21. Verdú EF, Armstrong D, Idström J-P, Labenz J, Stolte M, Börsch G, Blum AL. Intragastric pH during treatment with omeprazole: role of Helicobacter pylori and H pylori-associated gastritis. Scand J Gastroenterol 1996; 31: 1151-6.